Cargando…

Prospective Multicenter Trial Assessing the Impact of Positive Peritoneal Cytology Conversion on Oncological Outcome in Patients with Endometrial Cancer Undergoing Minimally Invasive Surgery with the use of an Intrauterine Manipulator: Positive Peritoneal Cytology Conversion and Its Association with Oncological Outcome in Endometrial Cancer

BACKGROUND: Minimally invasive surgery is the standard approach in early-stage endometrial cancer according to evidence showing no compromise in oncological outcomes, but lower morbidity compared with open surgery. However, there are limited data available on the oncological safety of the use of int...

Descripción completa

Detalles Bibliográficos
Autores principales: Siegenthaler, Franziska, Johann, Silke, Imboden, Sara, Samartzis, Nicolas, Ledermann-Liu, Haiyan, Sarlos, Dimitri, Eberhard, Markus, Mueller, Michael D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640429/
https://www.ncbi.nlm.nih.gov/pubmed/36057902
http://dx.doi.org/10.1245/s10434-022-12356-9
_version_ 1784825849167478784
author Siegenthaler, Franziska
Johann, Silke
Imboden, Sara
Samartzis, Nicolas
Ledermann-Liu, Haiyan
Sarlos, Dimitri
Eberhard, Markus
Mueller, Michael D.
author_facet Siegenthaler, Franziska
Johann, Silke
Imboden, Sara
Samartzis, Nicolas
Ledermann-Liu, Haiyan
Sarlos, Dimitri
Eberhard, Markus
Mueller, Michael D.
author_sort Siegenthaler, Franziska
collection PubMed
description BACKGROUND: Minimally invasive surgery is the standard approach in early-stage endometrial cancer according to evidence showing no compromise in oncological outcomes, but lower morbidity compared with open surgery. However, there are limited data available on the oncological safety of the use of intrauterine manipulators in endometrial cancer. PATIENTS AND METHODS: This prospective multicenter study included patients with endometrial cancer undergoing laparoscopic staging surgery with the use of an intrauterine manipulator. We obtained three different sets of peritoneal washings: at the beginning of the surgical procedure, after the insertion of the intrauterine manipulator, and after the closure of the vaginal vault. The rate of positive peritoneal cytology conversion and its association with oncological outcomes was assessed. RESULTS: A total of 124 patients were included. Peritoneal cytology was negative in 98 (group 1) and positive in 26 (group 2) patients. In group 2, 16 patients presented with positive cytology at the beginning of the surgery (group 2a) and 10 patients had positive cytology conversion during the procedure (group 2b). Recurrence rate was significantly different among the study groups, amounting to 9.2%, 25.0%, and 60.0% for groups 1, 2a, and 2b, respectively (p < 0.001). Group 1 showed the best recurrence-free and overall survival, followed by group 2a, while patients in group 2b had the worst oncological outcomes (p = 0.002 and p = 0.053, respectively). Peritoneal cytology was an independent predictor of recurrence and death on multivariable analysis. CONCLUSION: A total of 8.1% of patients with endometrial cancer undergoing minimally invasive surgery with intrauterine manipulation showed positive peritoneal cytology conversion associated with significantly worse oncological outcome.
format Online
Article
Text
id pubmed-9640429
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-96404292022-11-15 Prospective Multicenter Trial Assessing the Impact of Positive Peritoneal Cytology Conversion on Oncological Outcome in Patients with Endometrial Cancer Undergoing Minimally Invasive Surgery with the use of an Intrauterine Manipulator: Positive Peritoneal Cytology Conversion and Its Association with Oncological Outcome in Endometrial Cancer Siegenthaler, Franziska Johann, Silke Imboden, Sara Samartzis, Nicolas Ledermann-Liu, Haiyan Sarlos, Dimitri Eberhard, Markus Mueller, Michael D. Ann Surg Oncol Gynecologic Oncology BACKGROUND: Minimally invasive surgery is the standard approach in early-stage endometrial cancer according to evidence showing no compromise in oncological outcomes, but lower morbidity compared with open surgery. However, there are limited data available on the oncological safety of the use of intrauterine manipulators in endometrial cancer. PATIENTS AND METHODS: This prospective multicenter study included patients with endometrial cancer undergoing laparoscopic staging surgery with the use of an intrauterine manipulator. We obtained three different sets of peritoneal washings: at the beginning of the surgical procedure, after the insertion of the intrauterine manipulator, and after the closure of the vaginal vault. The rate of positive peritoneal cytology conversion and its association with oncological outcomes was assessed. RESULTS: A total of 124 patients were included. Peritoneal cytology was negative in 98 (group 1) and positive in 26 (group 2) patients. In group 2, 16 patients presented with positive cytology at the beginning of the surgery (group 2a) and 10 patients had positive cytology conversion during the procedure (group 2b). Recurrence rate was significantly different among the study groups, amounting to 9.2%, 25.0%, and 60.0% for groups 1, 2a, and 2b, respectively (p < 0.001). Group 1 showed the best recurrence-free and overall survival, followed by group 2a, while patients in group 2b had the worst oncological outcomes (p = 0.002 and p = 0.053, respectively). Peritoneal cytology was an independent predictor of recurrence and death on multivariable analysis. CONCLUSION: A total of 8.1% of patients with endometrial cancer undergoing minimally invasive surgery with intrauterine manipulation showed positive peritoneal cytology conversion associated with significantly worse oncological outcome. Springer International Publishing 2022-09-04 2022 /pmc/articles/PMC9640429/ /pubmed/36057902 http://dx.doi.org/10.1245/s10434-022-12356-9 Text en © The Author(s) 2022, corrected publication 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Gynecologic Oncology
Siegenthaler, Franziska
Johann, Silke
Imboden, Sara
Samartzis, Nicolas
Ledermann-Liu, Haiyan
Sarlos, Dimitri
Eberhard, Markus
Mueller, Michael D.
Prospective Multicenter Trial Assessing the Impact of Positive Peritoneal Cytology Conversion on Oncological Outcome in Patients with Endometrial Cancer Undergoing Minimally Invasive Surgery with the use of an Intrauterine Manipulator: Positive Peritoneal Cytology Conversion and Its Association with Oncological Outcome in Endometrial Cancer
title Prospective Multicenter Trial Assessing the Impact of Positive Peritoneal Cytology Conversion on Oncological Outcome in Patients with Endometrial Cancer Undergoing Minimally Invasive Surgery with the use of an Intrauterine Manipulator: Positive Peritoneal Cytology Conversion and Its Association with Oncological Outcome in Endometrial Cancer
title_full Prospective Multicenter Trial Assessing the Impact of Positive Peritoneal Cytology Conversion on Oncological Outcome in Patients with Endometrial Cancer Undergoing Minimally Invasive Surgery with the use of an Intrauterine Manipulator: Positive Peritoneal Cytology Conversion and Its Association with Oncological Outcome in Endometrial Cancer
title_fullStr Prospective Multicenter Trial Assessing the Impact of Positive Peritoneal Cytology Conversion on Oncological Outcome in Patients with Endometrial Cancer Undergoing Minimally Invasive Surgery with the use of an Intrauterine Manipulator: Positive Peritoneal Cytology Conversion and Its Association with Oncological Outcome in Endometrial Cancer
title_full_unstemmed Prospective Multicenter Trial Assessing the Impact of Positive Peritoneal Cytology Conversion on Oncological Outcome in Patients with Endometrial Cancer Undergoing Minimally Invasive Surgery with the use of an Intrauterine Manipulator: Positive Peritoneal Cytology Conversion and Its Association with Oncological Outcome in Endometrial Cancer
title_short Prospective Multicenter Trial Assessing the Impact of Positive Peritoneal Cytology Conversion on Oncological Outcome in Patients with Endometrial Cancer Undergoing Minimally Invasive Surgery with the use of an Intrauterine Manipulator: Positive Peritoneal Cytology Conversion and Its Association with Oncological Outcome in Endometrial Cancer
title_sort prospective multicenter trial assessing the impact of positive peritoneal cytology conversion on oncological outcome in patients with endometrial cancer undergoing minimally invasive surgery with the use of an intrauterine manipulator: positive peritoneal cytology conversion and its association with oncological outcome in endometrial cancer
topic Gynecologic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640429/
https://www.ncbi.nlm.nih.gov/pubmed/36057902
http://dx.doi.org/10.1245/s10434-022-12356-9
work_keys_str_mv AT siegenthalerfranziska prospectivemulticentertrialassessingtheimpactofpositiveperitonealcytologyconversionononcologicaloutcomeinpatientswithendometrialcancerundergoingminimallyinvasivesurgerywiththeuseofanintrauterinemanipulatorpositiveperitonealcytologyconversionanditsassociat
AT johannsilke prospectivemulticentertrialassessingtheimpactofpositiveperitonealcytologyconversionononcologicaloutcomeinpatientswithendometrialcancerundergoingminimallyinvasivesurgerywiththeuseofanintrauterinemanipulatorpositiveperitonealcytologyconversionanditsassociat
AT imbodensara prospectivemulticentertrialassessingtheimpactofpositiveperitonealcytologyconversionononcologicaloutcomeinpatientswithendometrialcancerundergoingminimallyinvasivesurgerywiththeuseofanintrauterinemanipulatorpositiveperitonealcytologyconversionanditsassociat
AT samartzisnicolas prospectivemulticentertrialassessingtheimpactofpositiveperitonealcytologyconversionononcologicaloutcomeinpatientswithendometrialcancerundergoingminimallyinvasivesurgerywiththeuseofanintrauterinemanipulatorpositiveperitonealcytologyconversionanditsassociat
AT ledermannliuhaiyan prospectivemulticentertrialassessingtheimpactofpositiveperitonealcytologyconversionononcologicaloutcomeinpatientswithendometrialcancerundergoingminimallyinvasivesurgerywiththeuseofanintrauterinemanipulatorpositiveperitonealcytologyconversionanditsassociat
AT sarlosdimitri prospectivemulticentertrialassessingtheimpactofpositiveperitonealcytologyconversionononcologicaloutcomeinpatientswithendometrialcancerundergoingminimallyinvasivesurgerywiththeuseofanintrauterinemanipulatorpositiveperitonealcytologyconversionanditsassociat
AT eberhardmarkus prospectivemulticentertrialassessingtheimpactofpositiveperitonealcytologyconversionononcologicaloutcomeinpatientswithendometrialcancerundergoingminimallyinvasivesurgerywiththeuseofanintrauterinemanipulatorpositiveperitonealcytologyconversionanditsassociat
AT muellermichaeld prospectivemulticentertrialassessingtheimpactofpositiveperitonealcytologyconversionononcologicaloutcomeinpatientswithendometrialcancerundergoingminimallyinvasivesurgerywiththeuseofanintrauterinemanipulatorpositiveperitonealcytologyconversionanditsassociat